Umberger Traci S 4

What Happened Traci S. Umberger, Kestra Medical Technologies' General Counsel and Chief Administrative Officer and a director, acquired 942 shares on June 30, 2026. The shares were purchased under the company’s 2025 Employee Stock Purchase Plan (ESPP) at $21.55 per share for a total of about $20,300. The transaction is reported as an award/acquisition (code A) and was exempt under Rule 16b-3.

Key Details

• Transaction date and price: 2026-06-30, 942 shares at $21.55 each (total ≈ $20,300).
• Plan and exemption: Shares purchased under the 2025 ESPP; transaction exempt under Rule 16b-3 (ESPP purchase period Jan 1–Jun 30, 2026).
• Discount: ESPP purchase price was 85% of Kestra’s closing price on June 29, 2026 (per filing).
• Shares owned after transaction: Not specified in this Form 4 filing.
• Holdings note: Reported holdings include unvested RSUs (filing footnote).
• Filing date/timeliness: Form 4 filed 2026-07-02 reporting the 6/30/2026 transaction; appears to be filed within the standard reporting window.

Context This was a purchase through the company’s ESPP (employee benefit plan) rather than an open-market buy or option exercise. ESPP purchases are common for employees and executives and are typically made at a discounted price; they are factual indications of acquisition but should not be taken alone as a signal of company prospects. The filing clarifies the mechanics (85% of the 6/29 close) and the exemption under Rule 16b-3.